Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

20.0%

9 terminated out of 45 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

16%

7 trials in Phase 3/4

Results Transparency

15%

4 of 27 completed with results

Key Signals

4 with results75% success

Data Visualizations

Phase Distribution

36Total
Not Applicable (12)
P 1 (7)
P 2 (10)
P 3 (3)
P 4 (4)

Trial Status

Completed27
Terminated9
Unknown7
Withdrawn1
Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 27 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT02556697Not ApplicableTerminated

In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients

NCT00683722Phase 2Completed

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

NCT04465461Not ApplicableCompletedPrimary

Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion

NCT06533371Not ApplicableRecruiting

Clinical-ultrasonographic Assessment of Pulmonary Emphysema

NCT02719184Completed

Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)

NCT04161235CompletedPrimary

Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV

NCT04012359CompletedPrimary

Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax

NCT01860898Not ApplicableCompleted

A Phase I Study of iPS Cell Generation From Patients With COPD

NCT01457833Not ApplicableCompletedPrimary

Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema

NCT04918706Phase 2UnknownPrimary

Allogeneic MSC Treatment for Pulmonary Emphysema

NCT01495780Not ApplicableCompleted

eRT Remote Health Monitoring

NCT02827721Unknown

Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02879331Not ApplicableUnknownPrimary

Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils

NCT01515709Completed

Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease

NCT01849159Phase 1WithdrawnPrimary

Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema

NCT01580215TerminatedPrimary

Long Term Follow up Investigation of Endobronchial Valves in Emphysema

NCT01869205Phase 3CompletedPrimary

The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients

NCT02468609Not ApplicableUnknown

Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT

NCT02382367Not ApplicableCompletedPrimary

Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema

NCT02107209Phase 2CompletedPrimary

Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema

Scroll to load more

Research Network

Activity Timeline